Taking forward the acquisition process,
Hyderabad-based Dr Reddy's Laboratories (DRL) has made a public offer starting Friday to acquire all shares of the Netherlands-based OctoPlus NV, a speciality pharmaceutical company.
OctoPlus NV is listed on Euronext stock exchange in Amsterdam, Netherlands.
"
Dr Reddy's , together with its subsidiaries, launches the recommended public offer to acquire all the issued and outstanding shares of OctoPlus NV, a service based speciality pharmaceutical company, at an offer price of 0.52 euro (cum dividend) per share," DRL said in statement.
The Indian drug major had on October 22 announced that it had decided to acquire OctoPlus NV for about 27.4 million euro (about Rs 193 crore).
"The offer period commences on December 14 at 09:00 CET and ends on February 08, 2013, at 18:00 CET, unless extended," it added.
"The acquisition process is expected to complete by the end of this financial year," G V Prasad, vice chairman and chief executive officer, DRL, had earlier said.
Shares of Dr Reddy's ended the day's trade 0.99 per cent lower at Rs 1,833.70 on the Bombay Stock Exchange.
With inputs from PTI 
Special 
